tradingkey.logo

Bioharvest Sciences Inc

BHST
View Detailed Chart

6.550USD

+0.230+3.64%
Close 04/25, 16:00ETQuotes delayed by 15 min
113.50MMarket Cap
LossP/E TTM

Bioharvest Sciences Inc

6.550

+0.230+3.64%
Intraday
1m
30m
1h
D
W
M
D

Today

+3.64%

5 Days

+15.93%

1 Month

+1.55%

6 Months

0.00%

Year to Date

+5.99%

1 Year

0.00%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts
BUY
Current Rating
14.667
Target Price
123.92%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

57
Total
8
Median
9
Average
Company name
Ratings
Analysts
Bioharvest Sciences Inc
BHST
2
Mondelez International Inc
MDLZ
30
Hershey Co
HSY
27
Kraft Heinz Co
KHC
24
General Mills Inc
GIS
22
Campbell's Co
CPB
22
1
2
3
...
12

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(1)
Neutral(2)
Buy(9)
Indicators
Sell(1)
Neutral(2)
Buy(3)
Indicators
Value
Direction
MACD(12,26,9)
0.183
Buy
RSI(14)
61.958
Neutral
STOCH(KDJ)(9,3,3)
75.728
Neutral
ATR(14)
0.521
Low Volatility
CCI(14)
176.436
Buy
Williams %R
23.280
Buy
TRIX(12,20)
0.003
Sell
StochRSI(14)
91.050
Overbought
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
6.227
Buy
MA10
5.951
Buy
MA20
5.899
Buy
MA50
5.793
Buy
MA100
5.846
Buy
MA200
5.878
Buy

News

More news coming soon, stay tuned...

Company

BioHarvest Sciences Inc. is a botanical synthesis company. The Company leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
Company codeBHST
CompanyBioharvest Sciences Inc
CEOMr. Ilan Sobel
Websitehttps://bioharvest.com/about/